Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

FJ Vojdeman; SEM Herman; N Kirkby; A Wiestner; MB van t Veer; GE Tjonnfjord; MA Itala-Remesg; E Kimby; MZ Farooqui; A Polliack; KL Wu; Jeanette Doorduijn; Wendimagegn Ghidey Alemayehu; S Wittebol; T Kozak; J Walewski; MCJ Abrahamse-Testroote; MHJ van Oers; CH Geisler; CU Niemann

doi:10.1080/10428194.2017.1285027

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

FJ Vojdeman, SEM Herman, N Kirkby, A Wiestner, MB van t Veer, GE Tjonnfjord, MA Itala-Remesg, E Kimby, MZ Farooqui, A Polliack, KL Wu, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, S Wittebol, T Kozak, J Walewski, MCJ Abrahamse-Testroote, MHJ van Oers, CH Geisler, CU Niemann

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2356-2362
Number of pages	7
Journal	Leukemia & Lymphoma
Volume	58
Issue number	10
DOIs	https://doi.org/10.1080/10428194.2017.1285027
Publication status	Published - 2017

Access to Document

10.1080/10428194.2017.1285027

http://hdl.handle.net/1765/97841

Cite this

Vojdeman, FJ., Herman, SEM., Kirkby, N., Wiestner, A., van t Veer, MB., Tjonnfjord, GE., Itala-Remesg, MA., Kimby, E., Farooqui, MZ., Polliack, A., Wu, KL., Doorduijn, J., Ghidey Alemayehu, W., Wittebol, S., Kozak, T., Walewski, J., Abrahamse-Testroote, MCJ., van Oers, MHJ., Geisler, CH., & Niemann, CU. (2017). Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia. Leukemia & Lymphoma, 58(10), 2356-2362. https://doi.org/10.1080/10428194.2017.1285027

@article{76fd4dd980f4476f82d492e8581679e3,

title = "Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia",

author = "FJ Vojdeman and SEM Herman and N Kirkby and A Wiestner and {van t Veer}, MB and GE Tjonnfjord and MA Itala-Remesg and E Kimby and MZ Farooqui and A Polliack and KL Wu and Jeanette Doorduijn and {Ghidey Alemayehu}, Wendimagegn and S Wittebol and T Kozak and J Walewski and MCJ Abrahamse-Testroote and {van Oers}, MHJ and CH Geisler and CU Niemann",

year = "2017",

doi = "10.1080/10428194.2017.1285027",

language = "Undefined/Unknown",

volume = "58",

pages = "2356--2362",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "10",

}

Vojdeman, FJ, Herman, SEM, Kirkby, N, Wiestner, A, van t Veer, MB, Tjonnfjord, GE, Itala-Remesg, MA, Kimby, E, Farooqui, MZ, Polliack, A, Wu, KL, Doorduijn, J, Ghidey Alemayehu, W, Wittebol, S, Kozak, T, Walewski, J, Abrahamse-Testroote, MCJ, van Oers, MHJ, Geisler, CH & Niemann, CU 2017, 'Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia', Leukemia & Lymphoma, vol. 58, no. 10, pp. 2356-2362. https://doi.org/10.1080/10428194.2017.1285027

TY - JOUR

T1 - Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

AU - Vojdeman, FJ

AU - Herman, SEM

AU - Kirkby, N

AU - Wiestner, A

AU - van t Veer, MB

AU - Tjonnfjord, GE

AU - Itala-Remesg, MA

AU - Kimby, E

AU - Farooqui, MZ

AU - Polliack, A

AU - Wu, KL

AU - Doorduijn, Jeanette

AU - Ghidey Alemayehu, Wendimagegn

AU - Wittebol, S

AU - Kozak, T

AU - Walewski, J

AU - Abrahamse-Testroote, MCJ

AU - van Oers, MHJ

AU - Geisler, CH

AU - Niemann, CU

PY - 2017

Y1 - 2017

U2 - 10.1080/10428194.2017.1285027

DO - 10.1080/10428194.2017.1285027

M3 - Article

VL - 58

SP - 2356

EP - 2362

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 10

ER -